Head & Neck/Thyroid Cancers
News
New guidelines focus on pediatric thyroid nodules and cancer
The American Thyroid Association has released the first-ever guidelines for the evaluation and management of thyroid nodules and cancer in...
News
Gene-testing predictive value can depend on institutional cancer prevalence
Molecular profiling for thyroid cancer may be useful to surgeons in a variety of scenarios, but results should be interpreted with proper...
News
RAI given to thyroid CA patients does not increase their breast malignancy occurrence, recurrence
A study showed that radioactive iodine therapy did not significantly increase the incidence of breast cancer subsequent to the diagnosis of...
News
Thyroid cancer gene screening questioned for indeterminate nodules
Key clinical point: The gene expression classifier testing for malignancy in indeterminate thyroid nodules is not always cost effective. Major...
News
Thyroid cancer outcomes worse for black and Hispanic young adults
African American and Hispanic adolescents and adults under the age of 40 years were more likely to die from differentiated thyroid cancer than...
Conference Coverage
ASA: Mutation testing aids decision making in thyroid cancer
Key clinical point: Genetic testing in those with thyroid cancer may aid perioperative decision making. Major finding: Distant metastases were...
Conference Coverage
AACE: How to safely skip radioactive iodine for low-grade thyroid cancer
Key clinical point: Thyroid cancer patients do not need radioactive iodine treatment if their nonsuppressed thyroglobulin is less than 2 ng/mL 2...
Conference Coverage
VIDEO: Elective neck dissection during primary surgery improves oral cancer survival
News
Upfront neck dissection boosts oral cancer survival
Key clinical point: Elective neck dissection at the time of primary surgery for oral cancers improves overall survival. Major finding: Elective...
News
Pembrolizumab active in head and neck cancer, regardless of HPV status
Key clinical point: Immunotherapy with pembrolizumab is active in patients with recurrent or metastatic head and neck cancer.
News
Oral cancer survival lower with positive margins, public insurance
Key clinical point: Treatment factors such as neck dissection, tumor margins, type of insurance, and health care facility impact 5-year survival...